EHT 1864,
EHT-1864,
EHT1864,
EHT 1864,
754240-09-0,
EHT-1864,
EHT1864,
EHT 1864 2HCl,
MFCD11114384,
5-(5-(7-(Trifluoromethyl)quinolin-4-ylthio)pentyloxy)-2-(morpholinomethyl)-4H-pyran-4-one dihydrochloride,
2-(morpholin-4-ylmethyl)-5-[5-[7-(trifluoromethyl)quinolin-4-yl]sulfanylpentoxy]pyran-4-one;dihydrochloride,
2-(Morpholinomethyl)-5-((5-((7-(trifluoromethyl)quinolin-4-yl)thio)pentyl)oxy)-4H-pyran-4-one dihydrochloride,
4H-Pyran-4-one,2-(4-morpholinylmethyl)-5-[[5-[[7-(trifluoromethyl)-4-quinolinyl]thio]pentyl]oxy]-,hydrochloride(1:2),
SCHEMBL384979,
CHEMBL3216441,
AMPD00240,
CTK8F0294,
C25H27F3N2O4S.2ClH,
EX-A513,
BCP09829,
2391AH,
s7482,
AKOS024457839,
AM85901,
CS-3154,
AK213145,
DA-41426,
HY-16659,
QC-11716,
RT-012454,
EHT 1864, >=98% (HPLC),
FT-0700491,
SW220265-1,
2-[(morpholin-4-yl)methyl]-5-[(5-{[7-(trifluoromethyl)quinolin-4-yl]sulfanyl}pentyl)oxy]-4H-pyran-4-one dihydrochloride,
4H-Pyran-4-one, 2-(4-morpholinylmethyl)-5-((5-((7-(trifluoromethyl)-4-quinolinyl)thio)pentyl)oxy)-, dihydrochloride,
5(5(7(trifluoromethyl)quinolin-4-ylthio)pentyloxy)-2-(morpholinomethyl)-4h-pyran-4-one dihydrochloride,
D0M9ER,
EHT-101,
EHT-206,
LSECOAJFCKFQJG-UHFFFAOYSA-N,
EHT-0101,
EHT-0206,
CID9938202,
CID 9938202,
B5487,
A13886,
5-(5-(7- -2- -4H-pyran-4-onedihydrochloride,
C506907,
Rac1 inhibitor (Alzheimer's disease/cancer),Exonhit,